Source: Pharma Manufacturing
More...
Novo Nordisk oral diabetes drug outperforms Lilly rival
The company's oral diabetes drug semaglutide was found to be better at lowering blood sugar levels than Jardiance from Eli Lilly and Boehringer Ingelheim